Lincoln Pharmaceuticals Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 618 as of 17 Feb 16:01 . The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 7.2 on March 2021 to 13.4 on March 2025 . This represents a CAGR of 13.23% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 34.3 on March 2021 to 57.3 on March 2025 . This represents a CAGR of 10.81% over 5 years The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 449.4 crore on March 2021 to ₹ 1104 crore on March 2025 . This represents a CAGR of 19.71% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 43002 crore on March 2021 to ₹ 109468 crore on March 2025 . This represents a CAGR of 20.55% over 5 years The revenue of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 181.47 crore as compare to the Sep '25 revenue of ₹ 170.6 crore. This represent the growth of 6.37% The revenue of Torrent Pharmaceuticals Ltd for the Dec '25 is ₹ 3290 crore as compare to the Sep '25 revenue of ₹ 3275 crore. This represent the growth of 0.46% The ebitda of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 38.74 crore as compare to the Sep '25 ebitda of ₹ 32.66 crore. This represent the growth of 18.62% The ebitda of Torrent Pharmaceuticals Ltd for the Dec '25 is ₹ 1065 crore as compare to the Sep '25 ebitda of ₹ 1043 crore. This represent the growth of 2.11% The net profit of Lincoln Pharmaceuticals Ltd changed from ₹ 23.67 crore to ₹ 28.6 crore over 7 quarters. This represents a CAGR of 11.42% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 457 crore to ₹ 635 crore over 7 quarters. This represents a CAGR of 20.68% The Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 4.83 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of -1.94% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 52.06 % on March 2021 to 10.76 % on March 2025 . This represents a CAGR of -27.04% over 5 years .

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
All the assets and business of the erstwhile partnership were transferred to the Company.
The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

About Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

FAQs for the comparison of Lincoln Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Lincoln Pharmaceuticals Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Lincoln Pharmaceuticals Ltd is 1,292 Cr while Market cap of Torrent Pharmaceuticals Ltd is 141,859 Cr

What are the key factors driving the stock performance of Lincoln Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Lincoln Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lincoln Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

As of May 3, 2026, the Lincoln Pharmaceuticals Ltd stock price is INR ₹645.4. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹4191.5.

How do dividend payouts of Lincoln Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Lincoln Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.